Loading clinical trials...
Loading clinical trials...
A Multicenter, Prospective, Randomized Controlled Modified Platform Trial Assessing the Efficacy of Multiple Human Placental-Based Skin Substitutes and Standard of Care Versus SOC Alone in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Conditions
Interventions
Standard of Care
Revita
+3 more
Locations
5
United States
SerenaGroup Omaha Research Center
Omaha, Nebraska, United States
Wound Care of Tulsa
Tulsa, Oklahoma, United States
SerenaGroup Research South
Jefferson Hills, Pennsylvania, United States
Armstrong County Memorial Hospital
Kittanning, Pennsylvania, United States
SerenaGroup Monroeville
Monroeville, Pennsylvania, United States
Start Date
July 16, 2024
Primary Completion Date
November 1, 2026
Completion Date
December 1, 2026
Last Updated
March 2, 2026
NCT06383013
NCT07541196
NCT07260656
NCT07039396
NCT07396376
NCT07116876
Lead Sponsor
StimLabs
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions